Real World Evidence

Charles Schwab Investment Management Inc. Sells 30,990 Shares of Veracyte Inc (NASDAQ:VCYT) | American Banking News | 10/6/2020

… PI of a recent $8M NIH award to Tufts to fund a national clinical trial studying the integration of targeted genomic sequencing into neonatal diagnosis and care and a $5M FDA award to generate real world evidence for neonatal clinical trials. Dr. Gary Noel, MD, FAAP, FIDSA, FPIDS is a pediatrician, specialist in infectious diseases and immunology and an expert in drug development, having spent more than 30 years in …

Generex Subsidiary NuGenerex Immuno-Oncology Announces World Class Scientific Advisory Board Appointments for its COVID-19 Vaccine Development Program | Globe Newswire | 10/6/2020

… PI of a recent $8M NIH award to Tufts to fund a national clinical trial studying the integration of targeted genomic sequencing into neonatal diagnosis and care and a $5M FDA award to generate real world evidence for neonatal clinical trials. Dr. Gary Noel, MD, FAAP, FIDSA, FPIDS is a pediatrician, specialist in infectious diseases and immunology and an expert in drug development, having spent more than 30 years in …

Generex Subsidiary NuGenerex Immuno-Oncology Announces World Class Scientific Advisory Board Appointments for its COVID-19 Vaccine Development Program | 10/6/2020

… PI of a recent $8M NIH award to Tufts to fund a national clinical trial studying the integration of targeted genomic sequencing into neonatal diagnosis and care and a $5M FDA award to generate real world evidence for neonatal clinical trials. Dr. Gary Noel, MD, FAAP, FIDSA, FPIDS is a pediatrician, specialist in infectious diseases and immunology and an expert in drug development, having spent more than 30 years in …

Causal inference methods for real world evidence: a case study of a target trial emulation | 9/24/2020

The scientific contributions of RWD science can be organized into three classes of tasks: description, prediction, and causal inference. Causal inference is of interest in RWE studies for safety and effectiveness. This talk will explain and apply a methodological framework for causal inference using RWD. Share on: The power of knowledge . The value of understanding . Why Us? Steeped in a tradition of rigor and process, we maintain a legacy of …

xCures, Inc., together with Cancer Commons and a confidential partner, to launch a virtual medical food trial in patients with pancreatic cancer | PR Newswire | 9/23/2020

… cancer,” said Jennifer R. Grandis , M.D., principal investigator of the study, “and offer patients the opportunity to participate in a clinical trial.” About xCures: xCures Inc. provides a clinical study platform that prospectively generates Real World Evidence for investigational and approved interventions. Through patient advocacy partners such as Cancer Commons, xCures enrolls patients and processes medical data. AI algorithms ensure that the patients are matched to the best programs on …

Global Real World Evidence Solutions Market Report 2020 | 9/22/2020

Real World Evidence Solutions the Real World Evidence Solutions industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Real World Evidence Solutions market size to maintain the average annual growth rate of XXX from XXX million $ in 2015 to XXX million $ in 2020, BisReport analysts believe that in the next few years, Real World Evidence Solutions market size will be further …

If The Left Wants To Win The Idea War, It Must Fight | by Wingfield | Sep, 2020 | Medium | 9/22/2020

Wingfield Follow Sep 22 · 5 min read Not like that (Credit: https://pixabay.com/photos/businessman-man-afraid-angry-3036181/ ) Not with fists or blocks or character assassinations Those tactics don’t work. Setting aside human behavior studies, there’s real world evidence that those tactics don’t work. When people hold beliefs that society deems unacceptable they don’t let go of them. They hide them- in the deepest, darkest recesses of their mind …

Medical Affairs Executive Director - North & South Dakota/Minnesota/Nebraska/Iowa (Ecosystem) : Fargo | 9/22/2020

… payers, and other key influencers in the region. In addition, they will identify opportunities to advance the care continuum and the delivery of healthcare through broad clinical and population health research opportunities that include Real World Evidence (RWE) and the ability to leverage the suite of Roche assets across Flatiron Health, Foundation Medicine, and Roche Diagnostics as appropriate. The MED will have field accountability with key customers in the ecosystem …

Real World Evidence,RWE,Biostatistician(Remote) | 9/21/2020

Real World Evidence(RWE) Analytics/HEOR Position Summary Provides statistical analysis and programming for all observational research project sponsored by the US Evidence Based Medicine (EBM) and clinical study database in study report. Roles/Responsibilities Utilize statistical knowledge of and expertise to provide statistical programming support for EBM studies, with a main focus of real-world observational studies, database examples: 1)US medical and pharmacy claims databases (e.g. MarketScan); 2 …

Avicanna’s $AVCN.ca RHO Phyto™ Rapid Act Sprays are Now Available Nation Wide in Canada Through Medical Cannabis by Shoppers™ $WEED.ca $CL.ca $HEXO.ca | 9/21/2020

Avicanna Rapid Act Spray RHO Phyto Rapid Act Sprays are now available nationwide in high ratios of CBD to THC and are designed for rapid absorption and with lemon-mint flavour on the Medical Cannabis by Shoppers portal. The Rapid Act Sprays are also available for the Medical Cannabis Real World Evidence Studies (MC-RWE) conducted by the University Health Network in partnerships with Medical Cannabis by Shoppers along side …

Real World Evidence & Research | AMCP.org | 9/21/2020

Lymphoma Resources A type of B-cell non-Hodgkin lymphoma (cancer of the immune system) that is usually aggressive (fast-growing). It is the most common type of non-Hodgkin lymphoma, and is marked by rapidly growing tumors in the lymph nodes, spleen, liver, bone marrow, or other organs. AMCP is pleased to work with Monjuvi to offer these resources to you. 9/21/20 …

Agendia Presents New Data Demonstrating MammaPrint’s Clinical Utility in Treatment Decisions for Ultra-Low Risk Breast Cancer Patients at the European Society for Medical Oncology Virtual Congress | PR Newswire | 9/17/2020

… their physicians the information they need to make the best decisions for the full treatment journey. The company currently offers two commercially-available genomic profiling tests, supported by the highest levels of clinical and real world evidence that provide comprehensive genomic information that can be used to identify the most effective breast cancer treatment possible for each patient. MammaPrint®, the 70-gene breast cancer recurrence assay, is the only FDA …

MedCity Pivot Podcast: A conversation with Aetion’s CEO about the growing emphasis of Real World Evidence - MedCity News | 9/17/2020

Health tech companies – especially digital therapeutics ones – have had a tough time working with pharma companies. Among tech vendors, Aetion is an exception in that category. It has developed a Real-World Evidence (RWE) platform being used by Sanofi and other pharma companies. As Covid-19 hit, the New York company entered into a research collaboration with the Food and Drug Administration to facilitate the understanding of what treatments are …

Seqirus Real World Evidence Published in Vaccine Highlights Value of Cell-Based Quadrivalent Influenza Vaccine in Preventing Influenza Related Hospitalizations in the U.S. 2017/18 Season | BioSpace | 9/16/2020

SUMMIT, N.J. Seqirus, a global leader in influenza prevention, today announced the publication of real-world evidence (RWE) on the company’s cell-based quadrivalent influenza vaccine (QIVc) in peer-reviewed medical journal Vaccine . Study results indicate QIVc was more effective compared with standard, egg-based quadrivalent vaccine (QIVe-SD) in preventing influenza-related hospitalizations/ER visits, all-cause hospitalizations, and hospitalizations/ER visits related to serious respiratory events. 1 Study …

NESTcc Announces First International Research Network Collaborator | 9/16/2020

… 09.16.20 The National Evaluation System for health Technology Coordinating Center ( NESTcc ), an initiative of the Medical Device Innovation Consortium ( MDIC ), has announced NorthWest EHealth (NWEH) and Discover-NOW, the Health Data Research Hub for Real World Evidence , as its newest Network Collaborator partnership and first international addition to its Research Network. The NESTcc Research Network is comprised of internationally recognized institutions with expertise in many medical device areas and access …

Seqirus Real World Evidence Published in Vaccine Highlights Value of Cell-Based Quadrivalent Influenza Vaccine in Preventing Influenza Related Hospitalizations in the U.S. 2017/18 Season | PR Newswire | 9/16/2020

SUMMIT, N.J. Seqirus, a global leader in influenza prevention, today announced the publication of real-world evidence (RWE) on the company’s cell-based quadrivalent influenza vaccine (QIVc) in peer-reviewed medical journal Vaccine . Study results indicate QIVc was more effective compared with standard, egg-based quadrivalent vaccine (QIVe-SD) in preventing influenza-related hospitalizations/ER visits, all-cause hospitalizations, and hospitalizations/ER visits related to serious respiratory events. 1 Study …

2020 Global Drug Repurposing Service Providers Market - A Look at Repurposed Drugs in the Fight Against COVID-19 | PR Newswire | 9/15/2020

… of services, encompassing both drug discovery operations and consultancy requirements. In fact, many such players claim to have developed proprietary platforms based on advanced technologies, such as big data analysis, artificial intelligence (AI) and real world evidence , in order to facilitate drug repurposing related decision-making. This upcoming industry has witnessed significant partnership activity in the last ten years, with service providers having established strategic collaborations with innovator companies, as …

WeSay Announces Valuable Product Reviews Resource for Vendors and CBD Users | 9/15/2020

… with everything a business needs to get more engagements and higher conversion rate. Yaron Burshtein, WeSay’s CEO, points out, “For the CBD industry, data has never been properly collected on large scale use. Bringing real world evidence , embracing the power of the crowd and enabling their voice (reviews) to be heard will bring this industry greater credibility.” WeSay gives CBD business owners vital tools to expand their scope and sell …

Agendia to Showcase New Data at the European Society for Medical Oncology Virtual Congress 2020 | PR Newswire | 9/14/2020

… their physicians the information they need to make the best decisions for the full treatment journey. The company currently offers two commercially-available genomic profiling tests, supported by the highest levels of clinical and real world evidence that provide comprehensive genomic information that can be used to identify the most effective breast cancer treatment possible for each patient. MammaPrint®, the 70-gene breast cancer recurrence assay, is the only FDA …

Disease Network Delineates the Disease Progression Profile of Cardiovascular Diseases | 9/10/2020

As Electronic Health Records (EHR) data accumulated explosively in recent years, the tremendous amount of patient clinical data provided opportunities to discover real world evidence . In this study, a graphical disease network, named progressive cardiovascular disease network (progCDN), was built based on EHR data from 14.3 million patients to delineate the progression profiles of cardiovascular diseases (CVD). The network depicted the dominant diseases in CVD development, such as the heart …

[Webinar] Getting Started With Real World Evidence | 9/9/2020

Real world evidence (RWE) is becoming increasingly important for stakeholders as they make decisions across product lifecycles. IQVIA has made an on-demand webinar available to help you learn what RWE approaches are best for your business and where can you start. Topics of discussion include: Real world methodology How regulatory bodies use RWE for decision making, The role that RWE can play in speeding up access to medicines for …

AI Applications for Clinical Trials Increase, Refining Endpoints, Quantifying Pain, & More | BioSpace | 9/7/2020

Artificial intelligence (AI) and machine learning (ML) are enabling clinical trial sponsors to fill in the gaps when real world evidence is incomplete or inconsistent. Trials suggest it can do even more, detecting early indicators of disease, and even quantifying pain. “Real world evidence (RWE) rarely has the same rigor as research data. RWE is collected through electronic health records (EHRs) as well as through clinical trials. Although agencies want …

Zen Garcia Vs. Globe Earth: The Key to Unlocking the True Cosmology | 9/7/2020

… up to new possibilities, like all are initially when forced to face the monumental truth that the earth cannot be spherical, as curvature is nonexistent. As I testified in court, when it comes to real world evidence , the actual process of determining the truth of this matter is as simple as conducting a curvature test and yet, so few were willing to do so, choosing to remain staunch supporters of …

Real World Evidence Market Factors Influencing the Growth of the Market | 9/7/2020

… and delays in drug development (and the subsequent increase in development costs). The base year considered for the study is 2017 and the forecast period includes 2018 to 2023. [157 Pages Report] The global real world evidence market is valued at 612.0 million in 2017 and projected to reach USD 1,348.1 million by 2023, at a CAGR of 14.3%. Objectives of the Study · To define, describe, and forecast the global …

Clinerion, Maxer Consulting partner to boost identification and recruitment of patients into clinical trials in Italy, promoting safer, more effective clinical outcomes | PRWeb | 9/3/2020

… trial sites and offering physicians more treatment options.” About Clinerion Clinerion accelerates clinical research and medical access to treatments for patients. We generate real-world data from our global network of partner hospitals for Real World Evidence analyses. Clinerion’s Patient Network Explorer radically improves the efficiency and effectiveness of clinical trial recruitment by offering data-driven protocol optimization, site feasibility evaluation and real-time patient search and identification to match …

COVID-19

Charles Schwab Investment Management Inc. Sells 30,990 Shares of Veracyte Inc (NASDAQ:VCYT) | 10/6/2020

… NEWSWIRE) – Generex Biotechnology Corporation ( www.generex.com ) (OTCQB: GNBT ) ( http://www.otcmarkets.com/stock/GNBT/quote ) today announced that the company has formed the COVID-19 Vaccine Scientific & Clinical Advisory Board (SAB) to help guide the clinical development program … diagnosis and care and a $5M FDA award to generate real world evidence for neonatal clinical trials. Dr. Gary Noel, MD, FAAP, FIDSA, FPIDS is a pediatrician, specialist in infectious diseases and immunology and an …

Food and Drug Administration

MedCity Pivot Podcast: A conversation with Aetion’s CEO about the growing emphasis of Real World Evidence - MedCity News | 9/17/2020

… category. It has developed a Real-World Evidence (RWE) platform being used by Sanofi and other pharma companies. As Covid-19 hit, the New York company entered into a research collaboration with the Food and Drug Administration to facilitate the understanding of what treatments are more effective in countering the SARS-CoV-2 virus that has claimed the lives of so many around the world. In this episode of the …

CDC

Seqirus Real World Evidence Published in Vaccine Highlights Value of Cell-Based Quadrivalent Influenza Vaccine in Preventing Influenza Related Hospitalizations in the U.S. 2017/18 Season | PR Newswire | 9/16/2020

… to reduce the incidence of seasonal influenza, but also a critical tool to protect public health by minimizing the burden of influenza on our healthcare systems.” The Centers for Disease Control and Prevention (CDC) recommends everyone six months and older without contraindications receive an annual influenza vaccine as the best way to prevent seasonal influenza. 3 Seasonal influenza vaccine effectiveness may vary each year; some of these factors may be …

HIPAA

Litmus Health Achieves HIPAA Compliance and NIST Cybersecurity Framework Adherence for Real World Data Infrastructure | PRWeb | 9/3/2020

Litmus Health Achieves HIPAA Compliance and NIST Cybersecurity Framework Adherence for Real World Data Infrastructure Share Article Litmus continues to lead on data security and privacy With the rise of real world data collection in … serves customers interested in the collection, management, and analysis of real world evidence, improving clinical trial veracity by ensuring data collection is held to the highest standards. “Data standards and security are the foundation for …

Electronic Health Records

National Evaluation System for health Technology Coordinating Center Announces First International Research Network Collaborator | Business Wire | 7/20/2020

… the Medical Device Innovation Consortium ( MDIC ), today announced NorthWest EHealth ( NWEH ) and Discover-NOW , the Health Data Research Hub for Real World Evidence, as its newest Network Collaborator partnership and first international addition to its … hospitals/medical centers. NESTcc Network Collaborators also have access to electronic health records (EHR), pharmacy data, public and private claims, registry data, patient-generated data, unique device identifiers (UDI), and supplemental data, including billing, supply …

Clinical Research

National Evaluation System for health Technology Coordinating Center Announces Launch of NEST 1.0 | Business & Finance | heraldchronicle.com | Business Wire | 6/30/2020

… evidence is needed to inform clinical decision-making and keep patients safe,” said Adrian Hernandez, M.D., MHS, professor of Medicine at Duke School of Medicine, vice dean and executive director of the Duke Clinical Research Institute, and chair of the NESTcc Governing Committee. “NESTcc is at the forefront driving transformative and scientifically sound research, and the ecosystem stands to benefit from the evidence resulting from NESTcc’s growth.” NESTcc enables the …

EMR

Real world evidence on 5661 patients treated for macular oedema secondary to branch retinal vein occlusion with intravitreal anti-vascular endothelial growth factor, intravitreal dexamethasone or macular laser | BMJ | 6/12/2020

PDF Clinical science Real world evidence on 5661 patients treated for macular oedema secondary to branch retinal vein occlusion with intravitreal anti-vascular endothelial growth factor, intravitreal dexamethasone or macular laser on behalf of UK EMR Users Group 1 Ophthalmology , Hightown Surgery , York , UK 2 York Teaching Hospital NHS Foundation Trust , York , North Yorkshire , UK 3 Institute of Health Informatics , University College London , London , London , UK 4 Department of Ophthalmology …

Digital Health

NCCN Policy Summit Explores 21st Century Cures Act and the Impact of Health Information Technology | PR Newswire | 6/10/2020

… of Food and Drugs , The Food and Drug Administration (FDA) held a fireside chat on clinical trials, data, and how real world evidence is changing the research landscape. Don Rucker , MD, MBA, MS , National Coordinator … Comprehensive Cancer Center and Clinical Informatics Lead , UCSF Center for Digital Health Innovation; and Susan Stiles , MHA, MBA, FACHE , Executive, Oncology Business Unit , Cerner Corporation. “Today, it takes an extraordinary effort for patients to access …

Biotechnology Innovation Organization

Scientist.com and HealthEconomics.Com Partner to Enable Online Sourcing of Health Economics and Outcomes Research (HEOR) and Real World Evidence (RWE) | Business Wire | 4/9/2020

Scientist.com and HealthEconomics.Com Partner to Enable Online Sourcing of Health Economics and Outcomes Research (HEOR) and Real World Evidence (RWE) The HEOR & RWE Marketplace connects buyers and sellers of HEOR and RWE April 09, 2020 … marketplaces for most of the world’s major pharmaceutical companies, the Biotechnology Innovation Organization (BIO) and the US National Institutes of Health (NIH). Since its founding in 2007, Scientist.com has raised $39 million from 5AM Ventures …

Medicaid

Avalere Health Partners With Leading Registry And Analytics Company, Corrona LLC, To Combine Economic And Clinical Outcomes Data For Autoimmune Diseases | PR Newswire | 3/17/2020

… data on more than 314 million unique patients spanning 53 billion medical events and more than 988,000 physicians across Medicare, Medicaid, and commercially insured markets. Corrona collects deep clinical data on validated physician assessments used … being of patients with autoimmune diseases.” About Corrona Corrona provides real world evidence through syndicated registry data and analysis services, helping biopharmaceutical companies demonstrate the value of their products to clinicians, patients, payers, and regulators …

Clinical Data

Anavex Life Sciences Presents ANAVEX®2-73 (blarcamesine) Data at 12th Clinical Trials on Alzheimer’s Disease (CTAD) 2019 Conference Nasdaq:AVXL | Globe Newswire | 12/4/2019

… 104-Week) Timepoint Abundance of Lachnospiraceae and Enterobacteriaceae Families as Potential Biomarker of Response from a 2-Year Study Interim Clinical Data Analysis of ANAVEX ® 2-73 ( blarcamesine ) NEW YORK, Dec. 04, 2019 (GLOBE NEWSWIRE) – Anavex … to improved response with ANAVEX®2-73 ( blarcamesine ).” FDA’s Framework for Real World Evidence document released in December 2018 demonstrates how Real World Evidence can be incorporated into regulatory decision-making. This framework was applied to …

Clinical Trials Data

COTA Presents Posters at ASH Annual Meeting, Reviewing Complexities of Generating RWD and How it Complements Traditional Clinical Trial Data | PR Newswire | 12/4/2019

BOSTON , Dec. 4, COTA, Inc., a healthcare technology company that uses real-world data (RWD) to bring clarity to cancer care, is presenting posters at the American Society of Hematology Annual Meeting & Exposition, ASH 2019, in Orlando, FL from December 7-10, 2019 . Collectively, the posters review existing challenges for generating RWD and the promise of this data to support new research in cancer biology. “The genetic environment – whether of individual …

Patient Networks

Clinerion and Massive Bio partner to improve cancer patient lives | PRWeb | 12/3/2019

Clinerion and Massive Bio partner to improve cancer patient lives Share Article Clinerion, provider of the Patient Network Explorer platform which harnesses patient data from a global hospital network, and Massive Bio, provider of end-to-end patient enrollment services for oncology, partner to improve trial site selection and thereby offer better access for cancer patients to leading-edge clinical trials. BASEL, Switzerland Clinerion offers Massive Bio access to oncology …

Clinical Trial Recruitment

Clinerion and Massive Bio partner to improve cancer patient lives | PRWeb | 12/3/2019

… medical access to treatments for patients. We use proprietary technologies for analysis of patient data from our global network of partner hospitals. Clinerion’s Patient Network Explorer radically improves the efficiency and effectiveness of clinical trial recruitment by offering data-driven protocol optimization, site feasibility evaluation and real-time patient search and identification to match patients to treatments. Our technology solution provides real-world evidence analytics for medical access. Clinerion facilitates …

Patient Recruitment

Clinerion and Massive Bio partner to improve cancer patient lives | PRWeb | 12/3/2019

… better access for cancer patients to leading-edge clinical trials. BASEL, Switzerland Clinerion offers Massive Bio access to oncology patient insights for site outreach and identification of cohorts for trial site selection and patient recruitment. Clinerion’s Patient Network Explorer queries anonymized patient data from its international network of partner hospitals to deliver real-world health data insights useful for Massive Bio’s site outreach programs. Clinerion’s ANID technology meanwhile allows authorized …

Patient Identification

Clinerion and Massive Bio partner to improve cancer patient lives | PRWeb | 12/3/2019

… screening and inclusion in trials, speeding up patient recruitment. Massive Bio provides end-to-end patient enrollment technology and services in oncology clinical trials for patients treated at community practices. These services include patient identification/engagement, pre-screening, JIT site activation, and real-world data services. Massive Bio structures medical records, NGS results and clinical trials with its proprietary ontologies and Natural Language Processing (NLP) technology. Massive Bio has also …

Precision Medicine

TriNetX Expands into South Korea in Partnership with EvidNet | PR Newswire | 12/3/2019

… data research and improve the quality of medical treatment. EvidNet is revolutionizing the way of healthcare data innovation through generation of evidence from a fully integrated data network, ultimately pioneering new paradigms in precision medicine and efficient healthcare systems. For more information, visit EvidNet at www.evidnet.com . Media Contacts …

Medical Imaging

The three hurdles facing your RWE efforts and how to get over them | 12/2/2019

By Matthew Michela There are three big hurdles in the way of effective use of Real World Evidence (RWE). Each of them is more complex, harder to deal with and takes longer to implement than most people think. Fortunately, solutions for each one of these issues are also closer to being available than most people realize. 901678 Times Visited: 7864 THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE …

Virtual Care

Onduo Publishes Real-world Evidence Demonstrating Significant Improvement in Glycemic Control for Program Participants With Type 2 Diabetes | Business & Finance | heraldchronicle.com | Business Wire | 12/2/2019

… of 2.3%, from 10.7% to 8.3% (p 0.001). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191202005534/en/ Onduo (Graphic: Business Wire) Onduo operates a smartphone-based virtual care program for people with type 2 diabetes that offers remote lifestyle coaching from certified diabetes educators and health coaches, connected tools and devices, and access to clinical support from board-certified endocrinologists via a virtual …

Mental Health

Arabkir Joint Medical Center & Institute of Child and Adolescent Health joins Patient Network Explorer, expanding Clinerion’s global hospital network to Armenia | PRWeb | 11/21/2019

… Center & Institute of Child and Adolescent Health, in Yerevan, Armenia, has a wide specialization, which includes services for allergology, dermatovenereology, pediatric gastroenterology and hepatology, pediatric rheumatology, trauma and orthopedics, endocrinology and diabetes, pulmonology, mental health, pediatric gynecology, and neurology and epileptology, among others. The hospital has departments for hemodialysis and kidney transplantation, anesthesiology and intensive therapy, uro-surgery, ENT/otorhinolaryngology and plastic surgery, nephrology, and intensive care and resuscitation. Patient …

Biotech

MMS Holdings Doubles Growth in South Africa Region Amid Burgeoning Pharmaceutical Industry Locally | Business Wire | 11/20/2019

… MIT, the Center for Translational Medicine at the University of Maryland School of Pharmacy, and Julia Computing – to strategically use Real World Evidence (RWE) and provide data-driven insights, with a goal to shorten the … an award-winning, data-focused CRO that supports the pharmaceutical, biotech, and medical device industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience and a data-driven …

Medicare

Abiomed Medical Office Completes Review of Observational Analysis of Impella Presented at AHA - Business Wire | 11/19/2019

… were escalated from IABP had much higher cost, longer length of stay, and worse outcomes 1 (see Figure 2) . NIS is the largest all-payer database in the United States, containing data from Medicare, Medicaid and large commercial payers on more than seven million hospital stays. The Stretch et al. finding is consistent with the real-world Impella outcomes in cardiogenic shock published by O’Neill et al., which demonstrated a …

Patient Registry

Amgen And The Duke Clinical Research Institute Announce Initiation Of First Large-Scale Registry To Evaluate Real-World Lipid Management And The Effectiveness Of PCSK9 Inhibitors | PR Newswire | 11/15/2019

THOUSAND OAKS, Calif. , Nov. 15, 2019 /PRNewswire/ – Amgen (NASDAQ: AMGN ) in collaboration with the Duke Clinical Research Institute (DCRI) today announced plans to initiate the C ardio v ascular M ulti-dimensional Ob servational I nvestigation of the U se of PC S K9 inhibitors (cvMOBIUS) study—the first large-scale real-world study to assess lipid management and the impact of PCSK9 inhibitors on cardiovascular (CV) outcomes in clinical …

Advanced Analytics

Quantzig Offers Advanced HR Analytics Solutions to Help Businesses Enhance Workforce Performance Through Data-driven Decision Making | Request a FREE Demo | Business Wire | 11/14/2019

… development, and retention. Talk to our analytics experts about how we can provide tailored HR analytics solutions for you. Quantzig’s Real World Evidence Analytics Solutions Employee Attrition Modeling Employee Performance Analytics Employee Acquisition Analytics Our … analytics experts, “Our advanced HR analytics solutions are backed by advanced analytics tools and methodologies that facilitate the automation and verification of workforce data.” Benefits of HR Analytics Make smarter human capital management decisions Eliminate …

Population Health

Johnson & Johnson’s Blasine Penkowski Elected National Pharmaceutical Council Board Chair | PR Newswire | 11/13/2019

… a special focus on working with major stakeholders across the ecosystem who utilize real-world evidence and pharmacoeconomics to make population health decisions. At Janssen, Ms. Penkowski has led work to develop novel outcomes-based … Mark J. Nagy , MBA, Vice President, Global Patient Outcomes and Real World Evidence, Eli Lilly and Company (At-large) Justin McCarthy , JD, Senior Vice President, Patient and Health Impact, Pfizer Inc. (At-large) In addition …

Clinerion

Clinerion, Maxer Consulting partner to boost identification and recruitment of patients into clinical trials in Italy, promoting safer, more effective clinical outcomes | PRWeb | 9/3/2020

Clinerion, Maxer Consulting partner to boost identification and recruitment of patients into clinical trials in Italy, promoting safer, more effective clinical outcomes Share Article Clinerion’s Patient Network Explorer will leverage Maxer’s extended network of relations … world data from our global network of partner hospitals for Real World Evidence analyses. Clinerion’s Patient Network Explorer radically improves the efficiency and effectiveness of clinical trial recruitment by offering data-driven protocol optimization, site …

Eli Lilly

Cost-effectiveness analysis of ixekizumab versus secukinumab in patients with psoriatic arthritis and concomitant moderate-to-severe psoriasis in Spain | BMJ | 8/14/2020

Rheumatology Original research Cost-effectiveness analysis of ixekizumab versus secukinumab in patients with psoriatic arthritis and concomitant moderate-to-severe psoriasis in Spain 1 Real World Evidence Strategy and Analytics, Commercialisation and Outcomes , ICON , Munich , Germany 2 Access, Commercialisation and Communications , ICON , Munich , Germany 3 Health Outcomes and Real World Evidence , Eli Lilly and Company , Madrid , Spain 4 Global Patient Outcomes and Real World Evidence International , Eli Lilly and Company …

Quantzig

Market Tracking and Real World Drug Performance Analysis Helps a Pharmaceutical Firm Increase Market Share | Get in Touch to Learn More About Quantzig’s Real World Evidence Analytics Capabilities | Business Wire | 8/12/2020

LONDON–(BUSINESS WIRE)–Aug 12, 2020– Premier analytics service provider, Quantzig announces the completion of its real world evidence analytics engagement . The success story offers comprehensive insights into how they helped a leading pharma company to analyze future growth opportunities and track market shares based on the performance of two newly launched oral oncolytic drugs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200812005314 …

McKesson

Evidation Raises $45 Million Series D, Hires CCO To Accelerate Commercial Momentum and Expand Into Virtual Health | Business Wire | 7/1/2020

… build upon its existing evidence generation capabilities to offer real-time insights and digital tools to its network of nearly 4 million individuals. B Capital Group led the round, which includes new investors McKesson Ventures and Section 32 as well as existing investors Revelation Partners, Rethink Impact, and SV Health Investors. B Capital’s Adam Seabrook has joined Evidation’s Board of Directors. Sam Marwaha, Senior Partner at Boston Consulting Group and …

Saama Technologies

Leading Life Sciences and Information Technology Companies Join EndPandemic National Data Consortium to Integrate COVID-19 Clinical Data - Business Wire | 4/14/2020

… EndPandemic National Data Consortium partners are to be applauded for the speed with which they answered the call to protect and ensure public health,” said Kenneth Massey, Pharm.D., Chief Life Sciences Officer of Saama Technologies. “The integrated database developed by the Consortium will be a comprehensive, collective platform that will inform and accelerate medical experts’ abilities to arrive at actionable decisions in relation to COVID-19 clinical research.” The EndPandemic …

IQVIA

The Global Real World Evidence Solution Market is expected to grow from USD 849.89 Million in 2019 to USD 1,785.13 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 13.16% | PR Newswire | 4/13/2020

PRNewswire/ – Real World Evidence Solution Market Research Report by Component (Claims Data, Clinical Settings Data, Patient-powered Data, Pharmacy Data, and Services), by Therapeutic Area (Cardiovascular Disease, Immunology, Neurology, and Oncology), by End-User - Global … Clinigen Group plc, Cognizant, HealthiVibe, LLC, IBM Corporation, ICON plc, IQVIA, Mercy Technology Services, Oracle Corporation, PAREXEL International Corporation, Pharmaceutical Product Development, LLC, SAS Institute Inc., Syneos Health, Tornado Sistems SRL, and Turacoz. FPNV Positioning …

Parexel

The Global Real World Evidence Solution Market is expected to grow from USD 849.89 Million in 2019 to USD 1,785.13 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 13.16% | PR Newswire | 4/13/2020

PRNewswire/ – Real World Evidence Solution Market Research Report by Component (Claims Data, Clinical Settings Data, Patient-powered Data, Pharmacy Data, and Services), by Therapeutic Area (Cardiovascular Disease, Immunology, Neurology, and Oncology), by End-User - Global … IBM Corporation, ICON plc, IQVIA, Mercy Technology Services, Oracle Corporation, PAREXEL International Corporation, Pharmaceutical Product Development, LLC, SAS Institute Inc., Syneos Health, Tornado Sistems SRL, and Turacoz. FPNV Positioning Matrix:The FPNV Positioning Matrix evaluates …

Syneos Health

The Global Real World Evidence Solution Market is expected to grow from USD 849.89 Million in 2019 to USD 1,785.13 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 13.16% | PR Newswire | 4/13/2020

PRNewswire/ – Real World Evidence Solution Market Research Report by Component (Claims Data, Clinical Settings Data, Patient-powered Data, Pharmacy Data, and Services), by Therapeutic Area (Cardiovascular Disease, Immunology, Neurology, and Oncology), by End-User - Global … PAREXEL International Corporation, Pharmaceutical Product Development, LLC, SAS Institute Inc., Syneos Health, Tornado Sistems SRL, and Turacoz. FPNV Positioning Matrix:The FPNV Positioning Matrix evaluates and categorizes the vendors in the Real World Evidence Solution …

Allergan

China Gives Greenlight to Allergan’s XEN® Registration for the Surgical Management of Refractory Glaucoma | PR Newswire | 4/2/2020

China Gives Greenlight to Allergan’s XEN® Registration for the Surgical Management of Refractory Glaucoma News provided by Apr 02, 2020, 07:30 ET Share this article – XEN ® Becomes the First Medical Product Approved by Using Real World Evidence in China – DUBLIN , April 2, 2020 /PRNewswire/ – Allergan plc (NYSE: AGN ) today announced China’s National Medical Products Administration (NMPA) approved the registration of Allergan’s XEN ® Gel Stent on March 26, 2020 for the …

AbbVie

AbbVie UK Announces Collaboration With NorthWest EHealth to Generate Real World Evidence to Drive Improvements in Patient Care | 11/27/2019

AbbVie UK Announces Collaboration With NorthWest EHealth to Generate Real World Evidence to Drive Improvements in Patient Care (Ref: AbbVie) AbbVie and NorthWest EHealth intend to explore the underlying associations between autoimmune conditions, using technology to interrogate data from NHS general practices Greater Manchester’s population makes the region the ideal location to conduct the work This project is an example of the partnership approach envisaged by the UK Government’s Life …

Johnson & Johnson

Janssen Leverages Wearable Technology to Reimagine Clinical Trial Design | PR Newswire | 11/16/2019

TITUSVILLE, N.J. , Nov. 16, 2019 /PRNewswire/ – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the launch of the next evolution of digital clinical trial design with CHIEF-HF, the first-ever completely decentralized, mobile, indication-seeking clinical study. To accelerate the study and fast-track results, all contact with participants will be done virtually, with no in-person clinical visits required. Drawing on previous experience, the Company is utilizing …

Bristol-Myers

Medidata NEXT NYC 2019 Delivers Roadmap for Future Innovation in Clinical Research | Business Wire | 11/14/2019

… PPD. This honors customers who are leading the way to improve lives through technology by demonstrating a commitment to decreasing burden to trial participants with a patient-first approach. Data Insights & Innovation Award: Bristol-Myers Squibb. This showcases a customer who has utilized data insights to improve decision making and drive innovation across clinical development and launch readiness. Partnership of the Year: ICON Medical Imaging. The award recognizes a partnership …

Pfizer

Johnson & Johnson’s Blasine Penkowski Elected National Pharmaceutical Council Board Chair | PR Newswire | 11/13/2019

… Real World Evidence, Eli Lilly and Company (At-large) Justin McCarthy , JD, Senior Vice President, Patient and Health Impact, Pfizer Inc. (At-large) In addition to the executive committee, the Board of Directors made appointments to two standing Board-level committees. Jan Hansen , PhD, Vice President, Evidence for Access Medical Unit, U.S. Medical Affairs, Genentech, Inc., will serve as chair of the Board-level Research Committee, and Christine Marsh , MBA …

Boehringer Ingelheim

Johnson & Johnson’s Blasine Penkowski Elected National Pharmaceutical Council Board Chair | PR Newswire | 11/13/2019

… Executive Vice President and Chief Scientific Officer, Mallinckrodt Pharmaceuticals (Treasurer) Mark J. Nagy , MBA, Vice President, Global Patient Outcomes and Real World Evidence, Eli Lilly and Company (At-large) Justin McCarthy , JD, Senior Vice President … Committee, and Christine Marsh , MBA, Senior Vice President, Market Access, Boehringer Ingelheim Pharmaceuticals, Inc., will serve a second term as chair of the Strategic Advisory Group. These committees provide input to the Board on research …

Bristol-Myers Squibb

Johnson & Johnson’s Blasine Penkowski Elected National Pharmaceutical Council Board Chair | PR Newswire | 11/13/2019

Bristol-Myers Squibb (Vice Chair) Steven J. Romano , MD, Executive Vice President and Chief Scientific Officer, Mallinckrodt Pharmaceuticals (Treasurer) Mark J. Nagy , MBA, Vice President, Global Patient Outcomes and Real World Evidence, Eli Lilly and Company (At-large) Justin McCarthy , JD, Senior Vice President, Patient and Health Impact, Pfizer Inc. (At-large) In addition to the executive committee, the Board of Directors made appointments to two standing Board-level committees …

Medidata

Infographic: The State of Real World Evidence | 11/9/2019

Industry Insights Industry Insights Infographic: The State of Real World Evidence SHYFT Analytics, a Medidata company, is the leading platform for commercial and real-world data analytics with products designed specifically for the pharmaceutical, biotech, and medical device industry. SHYFT’s data analytics platform is the most efficient and scalable way to transform massive amounts of complex healthcare data into on-demand clinical and commercial insight. SHYFT is headquartered in Boston …

Merck

Associate Principal Scientist, Economic & Data Sciences - West Point, PA, , USA #jobs #West Point pls RT | 11/6/2019

Job Detail for Associate Principal Scientist, Economic & Data Sciences Job Location: Merck, West Point, PA, , USA Job Detail for Associate Principal Scientist, Economic & Data Sciences Job Location: Merck, West Point, PA, , USA Jobs In Associate Principal Scientist… Jobs In Associate Prin… Jobs In Associate… Job Description Economic and Data Sciences is part of our Company’s Center for Observational and Real World Evidence (CORE) The Center for Observational and Real-world …

Optum

VC-backed Mindstrong Health appoints CEO | PE Hub | 11/1/2019

… Daniel Graf as CEO. Prior to joining Mindstrong, Graf led product at Uber . Mindstrong is backed by ARCH Venture Partners, Optum Ventures, General Catalyst, Foresite Capital, Bezos Expeditions, Decheng Capital, Berggruen Holdings and One Mind … health system for people with serious mental illness. By gathering real world evidence, we can create a digital health future based on deep science and state-of-the-art technology that can meet the patient …

Propeller Health

Digital health is growing fast — but at what cost? | TechCrunch | 7/10/2019

Share on Twitter Chris Hogg is a digital health advocate interested in how new forms of health data are changing the relationship between physician and patient. As CCO of Propeller Health , he leads the company’s San Francisco office and oversees the pharma BD, health system and payer sales, clinical and medical affairs and data science teams. Silicon Valley is obsessed with growth. And for digital health startups, that obsession is …

WellDoc

Digital health is growing fast — but at what cost? | TechCrunch | 7/10/2019

… days of digital health, I think we were much more focused on the patient than we are now. When I think of the early digital health companies — not just Propeller, but Omada Health, WellDoc, Ginger.io and Mango Health — all of their founders had an innate understanding of the importance of health outcomes. They craved proof that their product worked. They might have “faked it” a little bit when it came …

Omada Health

Digital health is growing fast — but at what cost? | TechCrunch | 7/10/2019

… the early days of digital health, I think we were much more focused on the patient than we are now. When I think of the early digital health companies — not just Propeller, but Omada Health, WellDoc, Ginger.io and Mango Health — all of their founders had an innate understanding of the importance of health outcomes. They craved proof that their product worked. They might have “faked it” a little bit when …

Flatiron Health

FDA Leverages Private Sector Technology Based Tools In Its Embrace Of Real World Evidence | Forbes | 7/9/2019

… label expansion and regulatory oversight tasks. The agency has signaled its apparent change of heart with speeches, policy guidance, and now with two public-private partnerships: the recent expansion of its agreement with Flatiron Health , and a brand new collaboration with COTA Healthcare . The Flatiron collaboration initially focused on patients being treated with immunotherapy for advanced non-small cell lung cancer; the new work concerns “the use of RWE in …

Biogen

Biosimilars: The Importance of Real-World Evidence (2019) Featuring Sandoz, Avalere, and Biogen - ResearchAndMarkets.com | Business Wire | 6/25/2019

… strategy, what evidence do they want and, more importantly, what data sources will deliver? In this new report, Biosimilars: The Importance of Real-World Evidence , experts from companies such as Sandoz, Avalere, and Biogen reveal their insights on the practical issues and challenges of cost-effectively generating powerful RWE that really drives physician understanding, increases patient confidence and positively influences wider stakeholders. Biosimilar Experts Tackle Key Questions What role does …

Medidata Solutions

Dassault Systèmes and Medidata Solutions To Join Forces To Accelerate the Life Sciences Industry Innovation For Patient-Centric Experience Through End-to-End Collaborative Platform – Company Announcement - FT.com | Financial Times | 6/12/2019

Medidata Solutions ’ market-leading clinical cloud solutions are used by 1,300 customers worldwide to develop their therapeutic innovations and clinical operations performance Scientific modeling, simulation and digital assets of worldwide trials knowledge and know-how … solutions on the 3DEXPERIENCE collaborative platform. Medidata’s recent expansion into real world evidence and analytics coupled with the power of modeling and simulation demonstrates how the virtual world will catalyze the next generation of patient …

Goldman Sachs

Syneos Health, Inc. (SYNH) CEO Alistair Macdonald on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 11/3/2019

… Participants Sandy Draper - SunTrust Erin Wright - Credit Suisse David Windley - Jefferies Eric Coldwell - Baird Tycho Peterson - JP Morgan Robert Jones - Goldman Sachs John Kreger - William Blair Elizabeth Anderson - Evercore ISI Dan Brennan - UBS Stephen Baxter … to, whether it fails in clinical or it goes through Real World Evidence, et cetera, all the way through to commercialization. We’ll be engaged with this customer all the way along with that asset. So …

McKesson Corporation (MCK) CEO Brian Tyler on Q2 2020 Results - Earnings Call Transcript | Seeking Alpha | 10/30/2019

… Research LLC Michael Cherny - Bank of America Merrill Lynch Charles Rhyee - Cowen & Company Steven Valiquette - Barclays Bank PLC Robert Jones - Goldman Sachs & Co. Kevin Caliendo - UBS Operator Good day, and welcome to McKesson’s Q2 Earnings … and a suite of data services providing commercial insights and real world evidence. These services help ensure biopharma manufacturers are successful in the post-launch commercialization of their products. These three businesses are well-positioned …

William Blair

Syneos Health, Inc. (SYNH) CEO Alistair Macdonald on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 11/3/2019

… Erin Wright - Credit Suisse David Windley - Jefferies Eric Coldwell - Baird Tycho Peterson - JP Morgan Robert Jones - Goldman Sachs John Kreger - William Blair Elizabeth Anderson - Evercore ISI Dan Brennan - UBS Stephen Baxter - Wolfe Research Operator Good … to, whether it fails in clinical or it goes through Real World Evidence, et cetera, all the way through to commercialization. We’ll be engaged with this customer all the way along with that asset. So …

Exact Sciences Corporation (EXAS) CEO Kevin Conroy on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 5/1/2019

… Jeff Elliott - CFO Mark Stenhouse - President of Cologuard Conference Call Participants Patrick Donnelly - Goldman Sachs Brandon Couillard - Jefferies Brian Weinstein - William Blair Doug Schenkel - Cowen & Company Catherine Schulte - Robert W. Baird Dan Brennan - UBS Puneet … detection. In addition to our pipeline work, we will present real world evidence supporting continued Cologuard use for providers and guideline groups at DDW. One of the liquid biopsy tests we’re working on in collaboration …

Merrill Lynch

McKesson Corporation (MCK) CEO Brian Tyler on Q2 2020 Results - Earnings Call Transcript | Seeking Alpha | 10/30/2019

… Eric Percher - Nephron Research Lisa Gill - JPMorgan Brian Tanquilut - Jefferies Stephen Baxter - Wolfe Research LLC Michael Cherny - Bank of America Merrill Lynch Charles Rhyee - Cowen & Company Steven Valiquette - Barclays Bank PLC Robert Jones - Goldman Sachs … and a suite of data services providing commercial insights and real world evidence. These services help ensure biopharma manufacturers are successful in the post-launch commercialization of their products. These three businesses are well-positioned …

Allscripts Healthcare Solutions, Inc. (MDRX) CEO Paul Black on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 5/3/2019

… CEO Rick Poulton - President Dennis Olis - CFO Stephen Shulstein - VP of IR Conference Call Participants Michael Cherny - Bank of America Merrill Lynch Jamie Stockton - Wells Fargo Robert Jones - Goldman Sachs Charles Rhyee - Cowen & Company Richard … unique value in these end markets. We use our expansive real world evidence combined data set of more than 150 million unique patient records to provide advanced analytic solutions and insights focused on improving care …

Morgan Stanley

Eli Lilly and Company (LLY) Presents Webcast to Discuss ADA Presentations and Diabetes Portfolio Conference (Transcript) | Seeking Alpha | 6/10/2019

… Global Development Leader, Incretins Jeffrey Emmick - VP, Diabetes Product Development Louise Chen - Cantor Fitzgerald Chris Schott - JP Morgan David Risinger - Morgan Stanley Terence Flynn - Goldman Sachs Umer Raffat - Evercore Vamil Divan - Credit Suisse Seamus Fernandez … patients with type 2 diabetes from a broader perspective. The real world evidence or RWE study recently published in the journal diabetes, obesity and metabolism assess the proportion of U.S. patients with type 2 diabetes …

Haemonetics Corporation (HAE) CEO Chris Simon on Q4 2019 Results - Earnings Call Transcript | Seeking Alpha | 5/11/2019

… Participants Olga Vlasova – Investor Relations Chris Simon – Chief Executive Officer Bill burke – Chief Financial Officer Conference Call Participants David Lewis – Morgan Stanley Anthony Petrone – Jefferies Dave Turkaly – JMP Securities Larry Keusch – Raymond James Mike Petusky … positioned to support this industry growth. And we have compelling real world evidence that gives us confidence in our value proposition and our continued progress towards upgrading customers to the new system. Customers have now …

MD Anderson Cancer Center

FDA rotating commissioner’s chair finds new nominee, former national coordinator joins Google, and more digital health hires and departures | MobiHealthNews | 11/5/2019

… acting commissioner of the FDA, with President Donald Trump pointing to Dr. Stephen Hahn , currently the chief medical officer of MD Anderson Cancer Center, as his official appointment for the role on Friday. Assistant Secretary … united with a powerful multi-modal research tool that supports real world evidence collection,” Berlin said in a statement. “I am thrilled to join Backpack Health as the company continues innovating to support the evolving …

FDA’s rotating commissioner’s chair finds new nominee, former national coordinator joins Google, and more digital health hires and departures | MobiHealthNews | 11/5/2019

… acting commissioner of the FDA, with President Donald Trump pointing to Dr. Stephen Hahn , currently the chief medical officer of MD Anderson Cancer Center, as his official appointment for the role on Friday. Assistant Secretary … united with a powerful multi-modal research tool that supports real world evidence collection,” Berlin said in a statement. “I am thrilled to join Backpack Health as the company continues innovating to support the evolving …

Mayo Clinic

Janssen Presenting Data From Its Expanding Rheumatology Portfolio At The 2019 Annual Meeting Of The American College Of Rheumatology | PR Newswire | 10/31/2019

… Form and Profile-29 T-Scores with SF-36 in Rheumatoid Arthritis Patients Treated for 1 year: Results from a Real World Evidence- Based Study in the United States Monday, November 11 9:00-11:00 am Others … at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958815/ . Accessed October 2017. 4 Mayo Clinic. Psoriatic Arthritis. Available at: http://www.mayoclinic.org/diseases-conditions/psoriatic-arthritis/home/ovc-20233896 . Accessed October 2017. 5 2017 Mease PJ, et al. J …

Janssen Presenting Data From Its Expanding Rheumatology Portfolio At The 2019 Annual Meeting Of The American College Of Rheumatology - The Delaware County Daily Times | 10/31/2019

… of PROMIS Short Formand Profile-29 T-Scores with SF-36 inRheumatoid Arthritis Patients Treated for 1year: Results from a Real World Evidence-Based Study in the United States Monday, November 11 Psychometric Evaluation of … at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958815/ . Accessed October 2017. 4 Mayo Clinic. Psoriatic Arthritis. Available at: http://www.mayoclinic.org/diseases-conditions/psoriatic-arthritis/home/ovc-20233896 . Accessed October 2017. 5 2017 Mease PJ, et al. J …

Sinai Health System

PM360 Announces NASHNET, pioneered by The Kinetix Group, as a Finalist for Its 2019 Trailblazer Award | PR Newswire | 8/27/2019

… are affected by NAFLD, with most patients undiagnosed,” says Douglas Dieterich , MD, Director of the Institute for Liver Medicine, Mount Sinai Health System. “ Given this high prevalence of disease, cost effective risk stratification strategies need … challenges across the NASH spectrum, including care coordination, population health, real world evidence, and clinical trials. NASHNET is powered by The Kinetix Group and headquartered in NYC. About The Kinetix Group The Kinetix Group empowers …

Univision Joins NASHNET in Advancing Awareness of NASH in Latino Populations | PR Newswire | 6/12/2019

… high-volume chronic condition. “An estimated 30 percent of individuals in the U.S. are affected by NAFLD, with most patients undiagnosed,” says Douglas Dieterich , MD, Director of the Institute for Liver Medicine, Mount Sinai Health System, and charter member of NASHNET. “Given this high prevalence of disease, cost effective risk stratification strategies need to be proven and adopted to target more effective assessments and interventions for those patients at greater …

Carolyn Magill

MedCity Pivot Podcast: A conversation with Aetion’s CEO about the growing emphasis of Real World Evidence - MedCity News | 9/17/2020

… what treatments are more effective in countering the SARS-CoV-2 virus that has claimed the lives of so many around the world. In this episode of the MedCity pivot podcast, Aetion’s CEO, Carolyn Magill, talks about the importance of RWE and how it is being used in new drug applications and in negotiating value-based contracts. Here’s the full episode …

Ian Rentsch

Clinerion, Maxer Consulting partner to boost identification and recruitment of patients into clinical trials in Italy, promoting safer, more effective clinical outcomes | PRWeb | 9/3/2020

… Ian Rentsch, CEO of Clinerion. “Clinerion’s Patient Network Explorer matches patients to clinical research, creating greater access to international trials for Italian trial sites and offering physicians more treatment options.” About Clinerion Clinerion accelerates clinical research and medical access to treatments for patients. We generate real-world data from our global network of partner hospitals for Real World Evidence analyses. Clinerion’s Patient Network Explorer radically improves the efficiency and effectiveness …

Don Rucker

NCCN Policy Summit Explores 21st Century Cures Act and the Impact of Health Information Technology | Yahoo News | 6/10/2020

real world evidence is changing the research landscape. Don Rucker , MD, MBA, MS , National Coordinator for Health Information Technology , Office of the National Coordinator for Health IT (ONC) spoke about increasing the use of electronic medical records. NCCN Logo (C)NCCN(R) 2018. All rights reserved. Más “The Office of the National Coordinator for Health Information Technology’s 21 st Century Cures Act Final Rule will give patients unprecedented access and …

Clifford Goodman

NCCN Policy Summit Explores 21st Century Cures Act and the Impact of Health Information Technology | Yahoo News | 6/10/2020

… of Food and Drugs , The Food and Drug Administration (FDA) held a fireside chat on clinical trials, data, and how real world evidence is changing the research landscape. Don Rucker , MD, MBA, MS , National Coordinator … also a key theme for the panel discussion moderated by Clifford Goodman , PhD, Senior Vice President of The Lewin Group and featuring Jenny Ahlstrom , Founder , CrowdCare Foundation and Multiple Myeloma Patient; Clay Alspach , JD , Principa …

Kevin Lust

Scientist.com and HealthEconomics.Com Partner to Enable Online Sourcing of Health Economics and Outcomes Research (HEOR) and Real World Evidence (RWE) | Business Wire | 4/9/2020

Scientist.com and HealthEconomics.Com Partner to Enable Online Sourcing of Health Economics and Outcomes Research (HEOR) and Real World Evidence (RWE) The HEOR & RWE Marketplace connects buyers and sellers of HEOR and RWE April 09, 2020 … research projects while sequestered during the Covid-19 pandemic,” stated Kevin Lustig, Ph.D., CEO and Founder of Scientist.com. “Partnering with HealthEconomics.Com to create a virtual marketplace for HEOR and RWE will allow critical research to …

Kevin Lustig

Scientist.com and HealthEconomics.Com Partner to Enable Online Sourcing of Health Economics and Outcomes Research (HEOR) and Real World Evidence (RWE) | Business Wire | 4/9/2020

Scientist.com and HealthEconomics.Com Partner to Enable Online Sourcing of Health Economics and Outcomes Research (HEOR) and Real World Evidence (RWE) The HEOR & RWE Marketplace connects buyers and sellers of HEOR and RWE April 09, 2020 … research projects while sequestered during the Covid-19 pandemic,” stated Kevin Lustig, Ph.D., CEO and Founder of Scientist.com. “Partnering with HealthEconomics.Com to create a virtual marketplace for HEOR and RWE will allow critical research to …

Laura Wood

Global Real-World Evidence (RWE) Solutions Market Study 2019-2024 - Oncology Anticipated to Be the Dominant Segment | PR Newswire | 11/29/2019

… AND FUTURE TRENDS For more information about this report visit https://www.researchandmarkets.com/r/7axovt Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood , Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related …

Anirban Choudhury

Quantzig Offers Advanced HR Analytics Solutions to Help Businesses Enhance Workforce Performance Through Data-driven Decision Making | Request a FREE Demo | Business Wire | 11/14/2019

… development, and retention. Talk to our analytics experts about how we can provide tailored HR analytics solutions for you. Quantzig’s Real World Evidence Analytics Solutions Employee Attrition Modeling Employee Performance Analytics Employee Acquisition Analytics Our … pricing plans, visit: https://www.quantzig.com/request-for-proposal Contacts Quantzig Anirban Choudhury Marketing Manager US: +1 630 538 7144 UK: +44 208 629 1455 https://www.quantzig.com/contact-us …

Mark J. Nagy

Johnson & Johnson’s Blasine Penkowski Elected National Pharmaceutical Council Board Chair | PR Newswire | 11/13/2019

Mark J. Nagy , MBA, Vice President, Global Patient Outcomes and Real World Evidence, Eli Lilly and Company (At-large) Justin McCarthy , JD, Senior Vice President, Patient and Health Impact, Pfizer Inc. (At-large) In addition to the executive committee, the Board of Directors made appointments to two standing Board-level committees. Jan Hansen , PhD, Vice President, Evidence for Access Medical Unit, U.S. Medical Affairs, Genentech, Inc., will serve as chair …

Dan Leonard

Johnson & Johnson’s Blasine Penkowski Elected National Pharmaceutical Council Board Chair | PR Newswire | 11/13/2019

… efforts to bring smart health policy research and analysis to these pressing discussions,” said NPC President and Chief Executive Officer Dan Leonard . “As health spending and value top the national health care agenda, we’re excited … Mark J. Nagy , MBA, Vice President, Global Patient Outcomes and Real World Evidence, Eli Lilly and Company (At-large) Justin McCarthy , JD, Senior Vice President, Patient and Health Impact, Pfizer Inc. (At-large) In addition …

Robert Jones

Syneos Health, Inc. (SYNH) CEO Alistair Macdonald on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 11/3/2019

… Conference Call Participants Sandy Draper - SunTrust Erin Wright - Credit Suisse David Windley - Jefferies Eric Coldwell - Baird Tycho Peterson - JP Morgan Robert Jones - Goldman Sachs John Kreger - William Blair Elizabeth Anderson - Evercore ISI Dan Brennan - UBS … to, whether it fails in clinical or it goes through Real World Evidence, et cetera, all the way through to commercialization. We’ll be engaged with this customer all the way along with that asset. So …